Valuation: Formycon AG

Market Cap 350M 402M 331M 301M 562M 38.48B 565M 3.94B 1.53B 19.55B 1.51B 1.48B 62.6B P/E 2026 *
660x
P/E 2027 * 14.9x
Enterprise Value 464M 533M 439M 399M 746M 51.03B 749M 5.23B 2.02B 25.94B 2B 1.96B 83.02B EV / Sales 2026 *
6.39x
EV / Sales 2027 * 4.12x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day-0.20%
1 week-2.46%
Current month+2.91%
1 month+6.22%
3 months-0.90%
6 months+2.48%
Current year-22.66%
1 week 19.4
Extreme 19.4
20.75
1 month 18.02
Extreme 18.02
20.9
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
67.8
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 2022-06-30
Director of Finance/CFO 57 2023-03-31
Chief Tech/Sci/R&D Officer - 2022-06-30
Director TitleAgeSince
Director/Board Member 49 2020-12-09
Chairman 54 2024-06-11
Director/Board Member 54 2024-06-11
Date Insider Type Main position Quantity % Market Cap. Importance
2/21/25 Buy

Chief Technology Officer

160 0.0009%
4/29/24 Buy

Executive/Senior Manager

1,200 0.0068%
4/24/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-2.46%-8.76%-67.00% 405M
+1.23%+1.30%-0.69%+9.57% 45.91B
+0.23%+4.72%+44.32%+27.27% 44.25B
+0.52%-3.15%+349.53%+520.09% 41.99B
+1.55%+3.41%+6.40%+76.45% 39.58B
+1.75%-1.53%+12.22%+41.11% 31.08B
-0.20%+5.49%+23.57%+119.72% 17.21B
-3.49%-8.49% - - 16.27B
+2.92%+8.40%+22.46%+38.87% 14.96B
-2.45%+2.41%-3.16%-35.16% 13.42B
Average +0.19%+1.16%+49.54%+81.21% 26.51B
Weighted average by Cap. +0.58%+0.68%+72.09%+120.30%

Financials

2026 *2027 *
Net sales 72.66M 83.42M 68.76M 62.48M 117M 7.99B 117M 819M 317M 4.06B 313M 306M 13B 112M 129M 106M 96.63M 181M 12.36B 181M 1.27B 490M 6.28B 485M 474M 20.1B
Net income 343K 394K 325K 295K 551K 37.71M 554K 3.87M 1.5M 19.17M 1.48M 1.45M 61.36M 23.19M 26.63M 21.95M 19.94M 37.25M 2.55B 37.44M 261M 101M 1.3B 100M 97.79M 4.15B
Net Debt 114M 131M 108M 98.19M 183M 12.56B 184M 1.29B 498M 6.38B 493M 482M 20.43B 113M 130M 107M 97.51M 182M 12.47B 183M 1.28B 494M 6.34B 489M 478M 20.29B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
196
Date Price Change Volume
26-09-17 €19.80 -0.20% 1,873
26-09-16 €19.84 -2.75% 4,339
26-09-15 €20.40 +2.00% 1,825
26-09-14 €20.00 -2.91% 1,040
26-09-11 €20.60 0.00% 1,583
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.80EUR
Average target price
39.67EUR
Spread / Average Target
+100.34%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!